atenolol has been researched along with Heart Diseases in 25 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
Excerpt | Relevance | Reference |
---|---|---|
"Atenolol was given intravenously before and immediately after surgery and orally thereafter for the duration of hospitalization." | 2.68 | Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. ( Layug, EL; Mangano, DT; Tateo, I; Wallace, A, 1996) |
"Lycopus extract was tested in thyroxine treated hyperthyroid rats (0." | 1.33 | Extract of Lycopus europaeus L. reduces cardiac signs of hyperthyroidism in rats. ( Baumgartner, A; Biller, A; Hegger, M; Korte, B; Vonhoff, C; Winterhoff, H, 2006) |
" The study reported here was designed to show whether the pharmacokinetics of verapamil are influenced by concurrent treatment with three different beta-adrenoceptor blockers, and whether there is any pharmacodynamic interaction between these drugs." | 1.27 | Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol. ( Fitzsimons, TJ; Holt, D; Johnston, A; Warrington, SJ, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (24.00) | 18.7374 |
1990's | 11 (44.00) | 18.2507 |
2000's | 8 (32.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Torella, F | 1 |
de Cossart, L | 1 |
Dimitri, SK | 1 |
Edwards, PR | 1 |
Pulcrano, M | 1 |
Palmieri, EA | 1 |
Pagano, L | 1 |
Tauchmanova, L | 1 |
Rossi, A | 1 |
Fazio, S | 1 |
Lombardi, G | 1 |
Biondi, B | 1 |
Vonhoff, C | 1 |
Baumgartner, A | 1 |
Hegger, M | 1 |
Korte, B | 1 |
Biller, A | 1 |
Winterhoff, H | 1 |
Baumgart, P | 1 |
Neary, WD | 1 |
McCrirrick, A | 1 |
Foy, C | 1 |
Heather, BP | 1 |
Earnshaw, JJ | 1 |
Margolis, KL | 1 |
Piller, LB | 1 |
Ford, CE | 1 |
Henriquez, MA | 1 |
Cushman, WC | 1 |
Einhorn, PT | 1 |
Colon, PJ | 1 |
Vidt, DG | 1 |
Christian, R | 1 |
Wong, ND | 1 |
Wright, JT | 1 |
Goff, DC | 1 |
London, MJ | 1 |
Beattie, WS | 1 |
Wijeysundera, DN | 1 |
Karkouti, K | 1 |
McCluskey, S | 1 |
Tait, G | 1 |
Warrington, SJ | 1 |
Holt, D | 1 |
Johnston, A | 1 |
Fitzsimons, TJ | 1 |
Yusuf, S | 1 |
Sleight, P | 1 |
Rossi, P | 1 |
Ramsdale, D | 1 |
Peto, R | 1 |
Furze, L | 1 |
Sterry, H | 1 |
Pearson, M | 1 |
Motwani, R | 1 |
Parish, S | 1 |
Gray, R | 1 |
Bennett, D | 1 |
Bray, C | 1 |
Summers, L | 1 |
Casiglia, E | 1 |
Spolaore, P | 1 |
Mazza, A | 1 |
Ginocchio, G | 1 |
Colangeli, G | 1 |
Onesto, C | 1 |
Di Menza, G | 1 |
Pegoraro, L | 1 |
Ambrosio, GB | 1 |
Kerns, W | 1 |
Ransom, M | 1 |
Tomaszewski, C | 1 |
Kline, J | 1 |
Raymond, R | 1 |
Mangano, DT | 1 |
Layug, EL | 1 |
Wallace, A | 1 |
Tateo, I | 1 |
Eagle, KA | 1 |
Froehlich, JB | 1 |
Shapley-Quinn, K | 1 |
Newton, W | 1 |
Ho, T | 1 |
Taussig, D | 1 |
McAnulty, G | 1 |
Petros, JA | 1 |
Devereaux, PJ | 1 |
Ghali, WA | 1 |
Reis, SE | 1 |
Feldman, AH | 1 |
Vecchio, C | 1 |
Chiarella, F | 1 |
Lupi, G | 1 |
Bellotti, P | 1 |
Domenicucci, S | 1 |
Noguchi, K | 1 |
Ojiri, Y | 1 |
Nagamine, F | 1 |
Matsuzaki, T | 1 |
Sakanashi, M | 1 |
Pupita, F | 1 |
Ansuini, R | 1 |
Belogi, M | 1 |
Pupita, G | 1 |
Gaggi, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00000542] | Phase 3 | 0 participants | Interventional | 1993-08-31 | Completed | ||
[NCT00005197] | 0 participants | Observational | 1986-12-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for atenolol and Heart Diseases
Article | Year |
---|---|
Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Topics: Adrenergic beta-Antagonists; Atenolol; Heart Diseases; Heart Rate; Humans; Monitoring, Intraoperativ | 2008 |
9 trials available for atenolol and Heart Diseases
Article | Year |
---|---|
Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery.
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Administration Schedule; Emergency Service, Hospital; Fo | 2006 |
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthal | 2007 |
Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.
Topics: Administration, Oral; Atenolol; Electrocardiography; Female; Heart Diseases; Humans; Male; Middle Ag | 1983 |
An investigation into the effects of surgical stress on the fit and poor-risk patient including the modifying effects of relative analgesia and beta-blockade. Part IV. The effect of beta-blockade and relative analgesia on surgical stress.
Topics: Aged; Anesthesia, Dental; Atenolol; Double-Blind Method; Female; Heart; Heart Diseases; Humans; Male | 1981 |
Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL).
Topics: Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Clonidine; Drug Therapy, Combination; Female; Hea | 1994 |
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Disease-Free Survival; Dou | 1996 |
Atenolol for prevention of postsurgical cardiovascular events.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Double-Blind Method; Elective Surgical Procedures; Hear | 1997 |
Left ventricular thrombus in anterior acute myocardial infarction after thrombolysis. A GISSI-2 connected study.
Topics: Adult; Aged; Aspirin; Atenolol; Embolism; Female; Fibrinolytic Agents; Heart; Heart Diseases; Heart | 1991 |
Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Clinical Trials as Topic; Electrocardiography | 1985 |
15 other studies available for atenolol and Heart Diseases
Article | Year |
---|---|
Routine beta-blockade in vascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Amputation, Surgical; Analysis of Variance; Arteriosclerosis; Ate | 2003 |
Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraga
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Blood Pr | 2004 |
Extract of Lycopus europaeus L. reduces cardiac signs of hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Body Temperature; Body Weight; Eatin | 2006 |
[Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2006 |
Quo vadis, perioperative beta blockade? Are you "POISE'd" on the brink?
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Heart Disease | 2008 |
[Beta-blockers in geriatrics. Results of a symposium on Tenormin].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Heart Diseases; Humans; Hypertension | 1983 |
Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Drug Interactions; Female; Half-Life; | 1984 |
The effects of extracellular ions on beta-blocker cardiotoxicity.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Heart; Heart Diseases; Heart R | 1996 |
Reducing cardiovascular risk in patients undergoing noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Atenolol; Heart Diseases; Humans; Postoperative Complications; Premedic | 1996 |
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Coronary Disease; H | 1997 |
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Atenolol; Heart Diseases; Humans; Intraoperative Period; Postoperative | 1997 |
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Diseases; Humans; Intraoperative Peri | 1997 |
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Heart Diseases; Humans; Male; Sex Factors; Surgical P | 1997 |
When heart patients need non-heart operations.
Topics: Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Diseases; Humans; Postoperative Compl | 1999 |
Alleviation of myocardial dysfunction and abnormal lactate metabolism during coronary stenosis in dogs by ICI 118,551.
Topics: Angina Pectoris; Animals; Atenolol; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disea | 1989 |